Literature DB >> 8948439

Cloning and analysis of human gastric mucin cDNA reveals two types of conserved cysteine-rich domains.

L W Klomp1, L Van Rens, G J Strous.   

Abstract

Human gastric mucin was isolated by successive CsCl-gradient ultracentrifugation in the presence of guanidinium hydrochloride to prevent degradation of the polypeptide moieties of the molecules. The amino acid sequence of a tryptic fragment of this molecule was identical to that of a tryptic fragment of tracheobronchial mucin. An oligonucleotide based on this sequence hybridized specifically to human stomach mRNA and was subsequently used to screen a human stomach lambda ZAPII cDNA library. The largest of 10 positive clones encoded 850 amino acid residues, including the tryptic fragment, with high amounts of threonine, serine and proline residues. Interestingly, cysteine accounted for almost 8% of the amino acid residues. The 3' part of the sequence was very similar but not identical to the 3' region of human tracheobronchial cDNA. No tandem repeated sequences were present and the deduced polypeptide sequence contained two potential N-linked glycosylation sites. Four cysteine-rich clusters were detected, one of which was apparently homologous to the D-domains present in other mucins and in von Willebrand factor. The arrangement of the cysteines in three other cysteine-rich clusters was conserved in the human gastric mucin cDNA in a similar fashion as in two domains in the MUC2 gene product. The cysteine-rich domains were separated by short stretches of non-repetitive amino acid residues with a very high content of threonine and serine residues. These data suggest that the encoded polypeptide of this clone may be involved in disulphide-bond-mediated oligomerization of the mucin, and provide new insights into the molecular organization of mammalian apomucins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8948439      PMCID: PMC1136799          DOI: 10.1042/bj3080831

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  von Willebrand factor biosynthesis and processing.

Authors:  T N Mayadas; D D Wagner
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Amino acid distributions around O-linked glycosylation sites.

Authors:  I B Wilson; Y Gavel; G von Heijne
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

3.  Porcine submaxillary mucin contains a cystine-rich, carboxyl-terminal domain in addition to a highly repetitive, glycosylated domain.

Authors:  A E Eckhardt; C S Timpte; J L Abernethy; Y Zhao; R L Hill
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

4.  Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs.

Authors:  N Porchet; V C Nguyen; J Dufosse; J P Audie; V Guyonnet-Duperat; M S Gross; C Denis; P Degand; A Bernheim; J P Aubert
Journal:  Biochem Biophys Res Commun       Date:  1991-03-15       Impact factor: 3.575

5.  Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization.

Authors:  J P Audie; A Janin; N Porchet; M C Copin; B Gosselin; J P Aubert
Journal:  J Histochem Cytochem       Date:  1993-10       Impact factor: 2.479

6.  Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor.

Authors:  J R Gum; J W Hicks; N W Toribara; B Siddiki; Y S Kim
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

7.  Human gastric mucin. Identification of a unique species by expression cloning.

Authors:  N W Toribara; A M Roberton; S B Ho; W L Kuo; E Gum; J W Hicks; J R Gum; J C Byrd; B Siddiki; Y S Kim
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

8.  The specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides.

Authors:  A P Elhammer; R A Poorman; E Brown; L L Maggiora; J G Hoogerheide; F J Kézdy
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

9.  Mannose 6-phosphate-independent membrane association of cathepsin D, glucocerebrosidase, and sphingolipid-activating protein in HepG2 cells.

Authors:  S Rijnboutt; H M Aerts; H J Geuze; J M Tager; G J Strous
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

10.  Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat.

Authors:  I Nishimori; N R Johnson; S D Sanderson; F Perini; K Mountjoy; R L Cerny; M L Gross; M A Hollingsworth
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

View more
  11 in total

1.  Genomic organization of the 3'-region of the human MUC5AC mucin gene: additional evidence for a common ancestral gene for the 11p15.5 mucin gene family.

Authors:  M P Buisine; J L Desseyn; N Porchet; P Degand; A Laine; J P Aubert
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

2.  Mucus glycoproteins from pig gastric mucosa: identification ofdifferent mucin populations from the surface epithelium.

Authors:  H Nordman; J R Davies; A Herrmann; N G Karlsson; G C Hansson; I Carlstedt
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

3.  Human mucin gene MUC5AC: organization of its 5'-region and central repetitive region.

Authors:  F Escande; J P Aubert; N Porchet; M P Buisine
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

4.  MUC2 is the prominent colonic mucin expressed in ulcerative colitis.

Authors:  K M Tytgat; F J Opdam; A W Einerhand; H A Büller; J Dekker
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

5.  Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa.

Authors:  R J Longman; J Douthwaite; P A Sylvester; R Poulsom; A P Corfield; M G Thomas; N A Wright
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

6.  Malignant and other properties of human colon carcinoma cells after suppression of sulfomucin production in vitro.

Authors:  H Tsuiji; S Nakatsugawa; T Ishigaki; T Irimura
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

7.  The human intestinal cell lines Caco-2 and LS174T as models to study cell-type specific mucin expression.

Authors:  B J van Klinken; E Oussoren; J J Weenink; G J Strous; H A Büller; J Dekker; A W Einerhand
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

8.  Lack of mucin MUC5AC field change expression associated with tubulovillous and villous colorectal adenomas.

Authors:  R J Longman; J Douthwaite; P A Sylvester; D O'Leary; B F Warren; A P Corfield; M G Thomas
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

Review 9.  The gastrointestinal mucus system in health and disease.

Authors:  Malin E V Johansson; Henrik Sjövall; Gunnar C Hansson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-12       Impact factor: 46.802

10.  Entamoeba histolytica cysteine proteinases disrupt the polymeric structure of colonic mucin and alter its protective function.

Authors:  Darcy Moncada; Kathy Keller; Kris Chadee
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.